Ibalizumab
ATC Code
J05AX23
Ibalizumab
Definition
A humanized monoclonal antibody against CD4, with anti-human immunodeficiency virus (HIV) activity. Ibalizumab binds to CD4, the primary receptor for HIV, thereby inhibiting HIV entry into CD4-positive T-cells. This leads to a reduction in viral load.
Also known as IBALIZUMAB, Ibalizumab-uiyk, Immunoglobulin G4, Anti-(Human CD4 (Antigen)) (Human-Mouse Monoclonal 5A8 Gamma-4-Chain), Disulfide with Human-Mouse Monoclonal 5A8 Kappa-Chain, Dimer, TNX-355, Trogarzo — per NCIT
Also identified as
- ATC J05AX23 per RXNORM
- NCIT NCIT:C88612 per NCIT
- SCTID 770963001 per RXNORM
- SCTID 771575008 per RXNORM
- UNII LT369U66CE per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| HIV infectious disease | may prevent | MEDRT · Public domain (U.S. Government work) |
| HIV infectious disease | may treat | MEDRT · Public domain (U.S. Government work) |